Condensed Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Net sales	$ 424.6	$ 490.9
Cost of sales	374.8	315.2
Gross profit	49.8	175.7
Selling, general and administrative expenses	122.9	152.5
Research and development expenses	28.3	37.2
Restructuring charges, net	1.2	6.8
Operating loss	(102.6)	(20.8)
Interest expense	162.0	58.2
Interest income	(4.7)	(0.4)
Other expense, net	(14.6)	(4.1)
Reorganization items, net	(5.6)	(43.4)
Loss from continuing operations before income taxes	(280.1)	(126.1)
Income tax benefit	(30.8)	(5.9)
Loss from continuing operations	(249.3)	(120.2)
Income from discontinued operations, net of income taxes	0.0	0.6
Net loss	$ (249.3)	$ (119.6)
Basic (loss) income per share (Note 5):
Loss from continuing operations	$ (18.93)	$ (1.42)
Income from discontinued operations	0	0.01
Net loss	$ (18.93)	$ (1.41)
Basic weighted-averaged shares outstanding (in shares)	13.2	84.7
Diluted (loss) income per share (Note 5):
Loss from continuing operations	$ (18.93)	$ (1.42)
Income from discontinued operations	0	0.01
Net loss	$ (18.93)	$ (1.41)
Diluted weighted-average shares outstanding (in shares)	13.2	84.7
Retained Earnings (Deficit)
Net loss	$ (249.3)	$ (119.6)